Journal
VIRUSES-BASEL
Volume 7, Issue 7, Pages 3647-3674Publisher
MDPI AG
DOI: 10.3390/v7072792
Keywords
Chikungunya virus; alphavirus; cell tropism; receptor; entry; endocytosis; clathrin; fusion; neutralizing antibodies; entry inhibitors
Categories
Funding
- Dutch Organization for Scientific Research (NWO - Earth and Life Sciences)
- Dutch Organization for Scientific Research (ASPASIA grant)
- Dutch Organization for Scientific Research (Veni grant) [863.13.015]
- University Medical Center Groningen
Ask authors/readers for more resources
Chikungunya virus (CHIKV) is a rapidly emerging mosquito-borne alphavirus causing millions of infections in the tropical and subtropical regions of the world. CHIKV infection often leads to an acute self-limited febrile illness with debilitating myalgia and arthralgia. A potential long-term complication of CHIKV infection is severe joint pain, which can last for months to years. There are no vaccines or specific therapeutics available to prevent or treat infection. This review describes the critical steps in CHIKV cell entry. We summarize the latest studies on the virus-cell tropism, virus-receptor binding, internalization, membrane fusion and review the molecules and compounds that have been described to interfere with virus cell entry. The aim of the review is to give the reader a state-of-the-art overview on CHIKV cell entry and to provide an outlook on potential new avenues in CHIKV research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available